Revised SPC: Multaq (dronedarone) 400mg film-coated tablets

SPC has been updated to advise that dronedarone is likely to increase the exposure of rivaroxaban (a CYP3A4 and P-gp substrate) and may increase the risk of bleeding, therefore concomitant use is not recommended.

Source:

electronic Medicines compendium